Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

A Deptor Inhibitor Induces Its Degradation with Resulting Anti-Myeloma Cytotoxicity in Vitro and In Vivo

Mario I Vega, PhD, Yijiang Shi, MD PhD, Patrick Frost, PhD, Sara Huerta-Yepez, PhD, Alan Lichtenstein, MD

Blood (2019) 134 (Supplement_1): 1821.

https://doi.org/10.1182/blood-2019-121480

Published: 2019

Journal Articles

Deptor As a Target with Chemical Inhibitors; Alternative Therapy in Multiple Myeloma

Mario Vega, PhD, Patrick Frost, PhD, Carolyne Bardeleben, PhD, Yijiang Shi, MD PhD, Sara Huerta-Yepez, PhD, Alan Lichtenstein, MD

Blood (2017) 130 (Supplement 1): 3833.

https://doi.org/10.1182/blood.V130.Suppl_1.3833.3833

Published: 2017

Journal Articles

Evaluating the Efficacy and Toxicity of Two Lenalidomide Dose Regimens for the Treatment of Older Relapsed Multiple Myeloma Patients with Co-Morbidities: A Multi-Site Study at the Veteran's Administration Hospitals

Sarvari V Yellapragada, MD, Shayna Sarosiek, MD, Neelima D Prabhala, B.A., Mehmet Kemalsamur, PhD, Antoun Houranieh, RPh., M.S., PhD, Saulius Girnius, MD, Praveen Tumula, MD, Suman Kambhampati, MD, Nirmala Bhoopalam, MD, Rao H Prabhala, PhD, David Roodman, MD, PhD, Alan Lichtenstein, MD, Nikhil C Munshi, MD

Blood (2015) 126 (23): 5370.

https://doi.org/10.1182/blood.V126.23.5370.5370

Published: 2015

Journal Articles

Mechanism Of Anti-Myeloma Effects Due To Silencing Of Deptor

Yonghui Yang, PhD, Alan Lichtenstein, MD

Blood (2013) 122 (21): 4428.

https://doi.org/10.1182/blood.V122.21.4428.4428

Published: 2013

Journal Articles

Identification and Characterization of Inhibitors That Specifically Target TORC2 in Multiple Myeloma

Bao Hoang, Joseph Gera, Alan Lichtenstein, MD

Blood (2012) 120 (21): 5026.

https://doi.org/10.1182/blood.V120.21.5026.5026

Published: 2012

Journal Articles

Anti-CD138-IFNα Fusion Proteins Are Effective in Treating Multiple Myeloma

Esther Yoo, PhD, Alex Vasuthasawat, Danh Tran, Alan Lichtenstein, MD, Sherie Morrison, PhD

Blood (2012) 120 (21): 939.

https://doi.org/10.1182/blood.V120.21.939.939

Published: 2012

Journal Articles

Targeting Deptor in Multiple Myeloma

Yonghui Yang, Joseph Gera, Alan Lichtenstein, MD

Blood (2012) 120 (21): 575.

https://doi.org/10.1182/blood.V120.21.575.575

Published: 2012

Journal Articles

Membrane Lipid Biosynthesis As a Potential Therapeutic Target in Multiple Myeloma

Carolyne Bardeleben, Alan Lichtenstein, MD

Blood (2012) 120 (21): 1836.

https://doi.org/10.1182/blood.V120.21.1836.1836

Published: 2012

Journal Articles

Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor

Bao Hoang, Patrick Frost, Yijiang Shi, Eileen Belanger, Angelica Benavides, Gholam Pezeshkpour, Susanna Cappia, Tommasina Guglielmelli, Joseph Gera, Alan Lichtenstein

Blood (2010) 116 (22): 4560–4568.

https://doi.org/10.1182/blood-2010-05-285726

Published: 2010

Includes: Supplemental data

Journal Articles

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2

Ken Maes, Elizabeta Nemeth, G. David Roodman, Alissa Huston, Flavia Esteve, Cesar Freytes, Natalie Callander, Eirini Katodritou, Lisa Tussing-Humphreys, Seth Rivera, Karin Vanderkerken, Alan Lichtenstein, Tomas Ganz

Blood (2010) 116 (18): 3635–3644.

https://doi.org/10.1182/blood-2010-03-274571

Published: 2010

Includes: Supplemental data

Journal Articles

Interleukin-6 (IL-6) Enhances C-MYC Translation IN MULTIPLE MYELOMA (MM) CELLS: ROLE of IL-6-INDUCED EFFECTS On the C-MYC RNA-Binding PROTEIN, HNRNPA1.

Yijiang Shi, Joseph Gera, Alan Lichtenstein, MD

Blood (2009) 114 (22): 3839.

https://doi.org/10.1182/blood.V114.22.3839.3839

Published: 2009

Journal Articles

Characterization of Hepcidin-Inducing Cytokines in Multiple Myeloma.

Ken Maes, Alissa Huston, MD, David Roodman, MD, PhD, Seth Rivera, MD, PhD, Elizabeta Nemeth, PhD, Alan Lichtenstein, MD, Karin Vanderkerken, PhD, Tomas Ganz, MD, PhD

Blood (2009) 114 (22): 2001.

https://doi.org/10.1182/blood.V114.22.2001.2001

Published: 2009

Journal Articles

Aberrant splicing of the E-cadherin transcript is a novel mechanism of gene silencing in chronic lymphocytic leukemia cells

Sanjai Sharma, Alan Lichtenstein

Blood (2009) 114 (19): 4179–4185.

https://doi.org/10.1182/blood-2009-03-206482

Published: 2009

Includes: Supplemental data

Journal Articles

Aberrant Splicing of the E-Cadherin Gene Is a Novel Mechanism of Gene Silencing in Chronic Lymphocytic Leukemia Cells

Sanjai Sharma, MD, MB, BS, Alan Lichtenstein, MD

Blood (2008) 112 (11): 2842.

https://doi.org/10.1182/blood.V112.11.2842.2842

Published: 2008

Journal Articles

Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors

Sanjai Sharma, Alan Lichtenstein

Blood (2008) 112 (4): 1338–1345.

https://doi.org/10.1182/blood-2007-11-124156

Published: 2008

Journal Articles

IL-6 Enhances C-myc Translation in Myeloma Cells Via Activation of the Myc Internal Ribosomal Entry Site (IRES) and an IRES-Binding Trans Factor, hnRNP A1.

Yijiang Shi, Joseph Gera, Alan Lichtenstein

Blood (2007) 110 (11): 3514.

https://doi.org/10.1182/blood.V110.11.3514.3514

Published: 2007

Journal Articles

Dexamethasone Induced Apoptotic Mechanisms in Myeloma Cells by Analysis of Mutant Glucocorticoid Receptors.

Sanjai Sharma, MD, Alan Lichtenstein, MD

Blood (2007) 110 (11): 2492.

https://doi.org/10.1182/blood.V110.11.2492.2492

Published: 2007

Journal Articles

The Role of AKT and ERK in Regulating D-Cyclin Translation Inhibition and G1 Arrest in Multiple Myeloma Cells Treated with mTOR Inhibitors: Rationale for Combination Thereapy.

Patrick J. Frost, PhD, YiJiang Shi, MD, Carolyne Bardalaban, PhD, Bao Hoang, PhD, Alan Lichtenstein, MD

Blood (2007) 110 (11): 4795.

https://doi.org/10.1182/blood.V110.11.4795.4795

Published: 2007

Journal Articles

Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma

Frederic Luciano, Maryla Krajewska, Paulina Ortiz-Rubio, Stan Krajewski, Dayong Zhai, Benjamin Faustin, Jean-Marie Bruey, Beatrice Bailly-Maitre, Alan Lichtenstein, Siva Kumar Kolluri, Arnold C. Satterthwait, Xiao-Kun Zhang, John C. Reed

Blood (2007) 109 (9): 3849–3855.

https://doi.org/10.1182/blood-2006-11-056879

Published: 2007

Includes: Supplemental data

Journal Articles

Targeting aurora kinases as therapy in multiple myeloma

Yijiang Shi, Tony Reiman, Weiqun Li, Christopher A. Maxwell, Subrata Sen, Linda Pilarski, Tracy R. Daniels, Manuel L. Penichet, Rick Feldman, Alan Lichtenstein

Blood (2007) 109 (9): 3915–3921.

https://doi.org/10.1182/blood-2006-07-037671

Published: 2007

NARROW

A Deptor Inhibitor Induces Its Degradation with Resulting Anti-Myeloma Cytotoxicity in Vitro and In Vivo

Deptor As a Target with Chemical Inhibitors; Alternative Therapy in Multiple Myeloma

Evaluating the Efficacy and Toxicity of Two Lenalidomide Dose Regimens for the Treatment of Older Relapsed Multiple Myeloma Patients with Co-Morbidities: A Multi-Site Study at the Veteran's Administration Hospitals

Mechanism Of Anti-Myeloma Effects Due To Silencing Of Deptor

Identification and Characterization of Inhibitors That Specifically Target TORC2 in Multiple Myeloma

Anti-CD138-IFNα Fusion Proteins Are Effective in Treating Multiple Myeloma

Targeting Deptor in Multiple Myeloma

Membrane Lipid Biosynthesis As a Potential Therapeutic Target in Multiple Myeloma

Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2

Interleukin-6 (IL-6) Enhances C-MYC Translation IN MULTIPLE MYELOMA (MM) CELLS: ROLE of IL-6-INDUCED EFFECTS On the C-MYC RNA-Binding PROTEIN, HNRNPA1.

Characterization of Hepcidin-Inducing Cytokines in Multiple Myeloma.

Aberrant splicing of the E-cadherin transcript is a novel mechanism of gene silencing in chronic lymphocytic leukemia cells

Aberrant Splicing of the E-Cadherin Gene Is a Novel Mechanism of Gene Silencing in Chronic Lymphocytic Leukemia Cells

Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors

IL-6 Enhances C-myc Translation in Myeloma Cells Via Activation of the Myc Internal Ribosomal Entry Site (IRES) and an IRES-Binding Trans Factor, hnRNP A1.

Dexamethasone Induced Apoptotic Mechanisms in Myeloma Cells by Analysis of Mutant Glucocorticoid Receptors.

The Role of AKT and ERK in Regulating D-Cyclin Translation Inhibition and G1 Arrest in Multiple Myeloma Cells Treated with mTOR Inhibitors: Rationale for Combination Thereapy.

Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma

Targeting aurora kinases as therapy in multiple myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only